000 | 01523 a2200433 4500 | ||
---|---|---|---|
005 | 20250517193127.0 | ||
264 | 0 | _c20190325 | |
008 | 201903s 0 0 eng d | ||
022 | _a1873-2763 | ||
024 | 7 |
_a10.1016/j.bone.2017.12.025 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMesser, J G | |
245 | 0 | 0 |
_aZoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis. _h[electronic resource] |
260 |
_bBone _c03 2018 |
||
300 |
_a79-88 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBisphosphonate-Associated Osteonecrosis of the Jaw _xepidemiology |
650 | 0 | 4 | _aBody Weight |
650 | 0 | 4 |
_aBone Resorption _xpathology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFemur _xpathology |
650 | 0 | 4 |
_aOsteocytes _xpathology |
650 | 0 | 4 |
_aPeriodontitis _xcomplications |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aSigmodontinae |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aZoledronic Acid _xadverse effects |
700 | 1 | _aMendieta Calle, J L | |
700 | 1 | _aJiron, J M | |
700 | 1 | _aCastillo, E J | |
700 | 1 | _aVan Poznak, C | |
700 | 1 | _aBhattacharyya, N | |
700 | 1 | _aKimmel, D B | |
700 | 1 | _aAguirre, J I | |
773 | 0 |
_tBone _gvol. 108 _gp. 79-88 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bone.2017.12.025 _zAvailable from publisher's website |
999 |
_c27936893 _d27936893 |